Sandoz announces positive results for biosimilar Denosumab EP News Bureau Sep 19, 2022 The results came soon after Sandoz confirmed acceptance of licence applications for two other proposed biosimilars
Osteoporosis drug may halve repeat hip replacement procedures: Study EP News Bureau Jan 14, 2021 Researchers from the University of Sheffield and Sheffield Teaching Hospitals found the osteoporosis drug, denosumab, could…
